Published in J Magn Reson Imaging on March 03, 2014
Automated two-point dixon screening for the evaluation of hepatic steatosis and siderosis: comparison with R2-relaxometry and chemical shift-based sequences. Eur Radiol (2014) 0.83
Retrospective comparison of gradient recalled echo R2* and spin-echo R2 magnetic resonance analysis methods for estimating liver iron content in children and adolescents. Pediatr Radiol (2015) 0.77
Magnetic resonance imaging findings compared with histological findings of the labrum in hip osteoarthritis. Skeletal Radiol (2015) 0.76
Segmentation and quantification of adipose tissue by magnetic resonance imaging. MAGMA (2015) 0.76
MRI Measurements of Iron Load in Transfusion-Dependent Patients: Implementation, Challenges, and Pitfalls. Pediatr Blood Cancer (2015) 0.75
Magnetic Resonanance Imaging of the Liver (Including Biliary Contrast Agents)-Part 2: Protocols for Liver Magnetic Resonanance Imaging and Characterization of Common Focal Liver Lesions. Semin Roentgenol (2016) 0.75
Validation of a new t2* algorithm and its uncertainty value for cardiac and liver iron load determination from MRI magnitude images. Magn Reson Med (2015) 0.75
T2* Measurement bias due to concomitant gradient fields. Magn Reson Med (2016) 0.75
Re: PC Adams. Genetic testing for hemochromatosis: Diagnostic or confirmatory test for iron overload? Can J Gastroenterol Hepatol 2015;29(1):15-6. Can J Gastroenterol Hepatol (2015) 0.75
Effects of Liver Fibrosis Progression on Tissue Relaxation Times in Different Mouse Models Assessed by Ultrahigh Field Magnetic Resonance Imaging. Biomed Res Int (2017) 0.75
Imaging patterns of fatty liver in pediatric patients. Diagn Interv Radiol (2015) 0.75
Diffusion-weighted imaging of the liver: Current applications. World J Radiol (2016) 0.75
High specificity targeting and detection of human neuroblastoma using multifunctional anti-GD2 iron-oxide nanoparticles. Nanomedicine (Lond) (2015) 0.75
Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care. J Magn Reson Imaging (2017) 0.75
Advanced imaging techniques in pediatric body MRI. Pediatr Radiol (2017) 0.75
Liver segmentation: indications, techniques and future directions. Insights Imaging (2017) 0.75
Liver biopsy. N Engl J Med (2001) 9.91
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J (2001) 8.90
Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab (2004) 8.36
The role of magnetic susceptibility in magnetic resonance imaging: MRI magnetic compatibility of the first and second kinds. Med Phys (1996) 4.94
MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood (2005) 4.79
Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn Reson Med (1994) 4.60
Hereditary hemochromatosis--a new look at an old disease. N Engl J Med (2004) 4.42
Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood (2004) 4.40
Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med (2000) 4.03
1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol (1985) 3.91
Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med (1985) 3.73
Diffusion-weighted MR imaging of the liver. Radiology (2010) 3.50
Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: validation and application to brain imaging. Magn Reson Med (2010) 3.43
Non-invasive assessment of hepatic iron stores by MRI. Lancet (2004) 3.38
Iron homeostasis. Annu Rev Physiol (2007) 3.22
Simultaneous spatial and spectral selective excitation. Magn Reson Med (1990) 3.20
In vivo characterization of the liver fat ¹H MR spectrum. NMR Biomed (2010) 3.07
Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology (1997) 2.83
Microscopic susceptibility variation and transverse relaxation: theory and experiment. Magn Reson Med (1994) 2.79
Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major. Blood (2005) 2.45
Magnetic-susceptibility measurement of human iron stores. N Engl J Med (1982) 2.35
Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology (1986) 2.30
Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology (2011) 2.28
Practical management of iron overload. Br J Haematol (2001) 2.25
Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy. Circulation (2005) 2.21
Effect of PRESS and STEAM sequences on magnetic resonance spectroscopic liver fat quantification. J Magn Reson Imaging (2009) 2.18
Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology (2010) 2.17
Improved R2* measurements in myocardial iron overload. J Magn Reson Imaging (2006) 2.09
Quantitative MR susceptibility mapping using piece-wise constant regularized inversion of the magnetic field. Magn Reson Med (2008) 2.09
R2* magnetic resonance imaging of the liver in patients with iron overload. Blood (2009) 2.05
Morphology enabled dipole inversion for quantitative susceptibility mapping using structural consistency between the magnitude image and the susceptibility map. Neuroimage (2011) 2.02
Interscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in thalassemia. J Magn Reson Imaging (2003) 1.96
Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy. Blood (2000) 1.84
Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury. Blood (2009) 1.83
Noninvasive measurement of iron: report of an NIDDK workshop. Blood (2002) 1.77
Advances in white matter imaging: a review of in vivo magnetic resonance methodologies and their applicability to the study of development and aging. Neurosci Biobehav Rev (2006) 1.77
EASL International Consensus Conference on Haemochromatosis. J Hepatol (2000) 1.76
Hepatic iron overload: diagnosis and quantification with MR imaging. AJR Am J Roentgenol (1997) 1.74
Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study. Neuroimage (2012) 1.74
Difference between the two iron-binding sites of transferrin. Nature (1975) 1.71
Multi-center validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron. Haematologica (2006) 1.66
On T2-shortening by weakly magnetized particles: the chemical exchange model. Magn Reson Med (2001) 1.61
Myocardial T2* measurements in iron-overloaded thalassemia: An in vivo study to investigate optimal methods of quantification. Magn Reson Med (2008) 1.60
Relaxation effects of clustered particles. J Magn Reson Imaging (2001) 1.57
The roles of iron in health and disease. Mol Aspects Med (2001) 1.55
Iron deposition and progression of disease in chronic hepatitis C. Role of interface hepatitis, portal inflammation, and HFE missense mutations. Am J Clin Pathol (2000) 1.52
Intercentre reproducibility of magnetic resonance T2* measurements of myocardial iron in thalassaemia. Int J Cardiovasc Imaging (2005) 1.51
Limits of detection of SPIO at 3.0 T using T2 relaxometry. Magn Reson Med (2005) 1.51
Hepatic hemosiderosis in non-human primates: quantification of liver iron using different field strengths. Magn Reson Med (1997) 1.46
Cerebral oxygen extraction fraction and cerebral venous blood volume measurements using MRI: effects of magnetic field variation. Magn Reson Med (2002) 1.41
Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation. Blood (2002) 1.40
R2* imaging of transfusional iron burden at 3T and comparison with 1.5T. J Magn Reson Imaging (2007) 1.38
Cardiac iron across different transfusion-dependent diseases. Blood Rev (2008) 1.37
Magnetic resonance imaging quantification of liver iron. Magn Reson Imaging Clin N Am (2010) 1.37
Physiology and molecular biology of dietary iron absorption. Annu Rev Nutr (2003) 1.37
Quantitative study of the variability of hepatic iron concentrations. Clin Chem (1999) 1.37
Single spin-echo proton transverse relaxometry of iron-loaded liver. NMR Biomed (2004) 1.36
Relaxation induced by ferritin: a better understanding for an improved MRI iron quantification. NMR Biomed (2004) 1.33
Secondary iron overload. Hematology Am Soc Hematol Educ Program (2001) 1.32
Hepatitis C, iron status, and disease severity: relationship with HFE mutations. Gastroenterology (2003) 1.26
Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques. Radiology (1999) 1.24
Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging. Radiology (1994) 1.23
Magnetic resonance imaging assessment of excess iron in thalassemia, sickle cell disease and other iron overload diseases. Hemoglobin (2008) 1.23
Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results. Radiology (2012) 1.23
Multicenter validation of the magnetic resonance T2* technique for segmental and global quantification of myocardial iron. J Magn Reson Imaging (2009) 1.21
Iron overload syndromes and the liver. Mod Pathol (2007) 1.20
International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers. J Magn Reson Imaging (2010) 1.14
Liver biopsy results in patients with sickle cell disease on chronic transfusions: poor correlation with ferritin levels. Pediatr Blood Cancer (2008) 1.14
Theory of nonexponential NMR signal decay in liver with iron overload or superparamagnetic iron oxide particles. Magn Reson Med (2002) 1.13
Iron as a co-morbid factor in nonhemochromatotic liver disease. Alcohol (2003) 1.12
Abdominal iron deposition: metabolism, MR findings, and clinical importance. Radiology (1996) 1.12
Bi-exponential proton transverse relaxation rate (R2) image analysis using RF field intensity-weighted spin density projection: potential for R2 measurement of iron-loaded liver. Magn Reson Imaging (2003) 1.11
MR imaging of the liver using short TI inversion recovery sequences. J Comput Assist Tomogr (1985) 1.11
Postprocessing technique to correct for background gradients in image-based R*(2) measurements. Magn Reson Med (2000) 1.10
Relaxivity-iron calibration in hepatic iron overload: probing underlying biophysical mechanisms using a Monte Carlo model. Magn Reson Med (2010) 1.09
Non-invasive quantitation of liver iron-overload by magnetic resonance imaging. Br J Haematol (1990) 1.07
In vivo comparison of myocardial T1 with T2 and T2* in thalassaemia major. J Magn Reson Imaging (2013) 1.06
Noninvasive methods for quantitative assessment of transfusional iron overload in sickle cell disease. Semin Hematol (2001) 1.06
R*(2) mapping in the presence of macroscopic B₀ field variations. Magn Reson Med (2011) 1.06
Iron overload in the liver diagnostic and quantification. Eur J Radiol (2006) 1.03
Familial hemochromatosis: characteristics of the precirrhotic stage in a large kindred. Medicine (Baltimore) (1977) 1.03
Phase and amplitude correction for multi-echo water-fat separation with bipolar acquisitions. J Magn Reson Imaging (2010) 1.02
Quantitative liver iron measurement by magnetic resonance imaging: in vitro and in vivo assessment of the liver to muscle signal intensity and the R2* methods. Magn Reson Imaging (2008) 1.02
Effects of spatial distribution on proton relaxation enhancement by particulate iron oxide. J Magn Reson Imaging (1995) 1.02
Multipeak fat-corrected complex R2* relaxometry: theory, optimization, and clinical validation. Magn Reson Med (2013) 1.02
Multicenter validation of spin-density projection-assisted R2-MRI for the noninvasive measurement of liver iron concentration. Magn Reson Med (2013) 1.01
Quantification of liver iron overload by T2 quantitative magnetic resonance imaging in thalassemia: impact of chronic hepatitis C on measurements. J Pediatr Hematol Oncol (1999) 1.00
Evaluation of iron overload by single voxel MRS measurement of liver T2. J Magn Reson Imaging (2002) 1.00
The use of appropriate calibration curves corrects for systematic differences in liver R2* values measured using different software packages. Br J Haematol (2013) 0.99
Gold storage in the liver: appearance on CT scans. Radiology (1986) 0.98
Rapid single-scan T2*-mapping using exponential excitation pulses and image-based correction for linear background gradients. Magn Reson Med (2009) 0.97
Liver iron concentration evaluated by two magnetic methods: magnetic resonance imaging and magnetic susceptometry. Magn Reson Med (2005) 0.97
Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C. Gastroenterology (2011) 0.95
CT and MRI of diffuse liver disease. Semin Ultrasound CT MR (1995) 0.95
Osteoporosis: clinical assessment with quantitative MR imaging in diagnosis. Radiology (1995) 0.94
Separate MRI quantification of dispersed (ferritin-like) and aggregated (hemosiderin-like) storage iron. Magn Reson Med (2010) 0.94
Anomalous nuclear magnetic relaxation of aqueous solutions of ferritin: an unprecedented first-order mechanism. Magn Reson Med (2002) 0.94
Liver iron content assessment by routine and simple magnetic resonance imaging procedure in highly transfused patients. Eur J Haematol (2006) 0.93
MRI assessment of liver iron content in thalassamic patients with three different protocols: comparisons and correlations. Eur J Haematol (2009) 0.92
Magnetic resonance imaging measurement of volume magnetic susceptibility using a boundary condition. J Magn Reson (1999) 0.91
Multiecho water-fat separation and simultaneous R2* estimation with multifrequency fat spectrum modeling. Magn Reson Med (2008) 4.50
Measurement of signal-to-noise ratios in MR images: influence of multichannel coils, parallel imaging, and reconstruction filters. J Magn Reson Imaging (2007) 4.18
Relaxation effects in the quantification of fat using gradient echo imaging. Magn Reson Imaging (2008) 4.13
Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise. Magn Reson Med (2007) 3.88
Multiecho reconstruction for simultaneous water-fat decomposition and T2* estimation. J Magn Reson Imaging (2007) 3.79
Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology (2009) 3.31
Heritability of nonalcoholic fatty liver disease. Gastroenterology (2009) 3.17
Decoding global gene expression programs in liver cancer by noninvasive imaging. Nat Biotechnol (2007) 3.17
Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology (2011) 3.08
In vivo characterization of the liver fat ¹H MR spectrum. NMR Biomed (2010) 3.07
Field map estimation with a region growing scheme for iterative 3-point water-fat decomposition. Magn Reson Med (2005) 2.82
Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging (2011) 2.75
Cramér-Rao bounds for three-point decomposition of water and fat. Magn Reson Med (2005) 2.63
Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology (2011) 2.42
CT and MR imaging of extrahepatic fatty masses of the abdomen and pelvis: techniques, diagnosis, differential diagnosis, and pitfalls. Radiographics (2005) 2.37
T(1) independent, T(2) (*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis. J Magn Reson Imaging (2011) 2.27
Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging. Radiology (2006) 2.23
Fatty liver: imaging patterns and pitfalls. Radiographics (2006) 2.21
Effect of PRESS and STEAM sequences on magnetic resonance spectroscopic liver fat quantification. J Magn Reson Imaging (2009) 2.18
Automated registration of sequential breath-hold dynamic contrast-enhanced MR images: a comparison of three techniques. Magn Reson Imaging (2011) 2.15
Whole-body CT screening: spectrum of findings and recommendations in 1192 patients. Radiology (2005) 2.14
Advances in pediatric nonalcoholic fatty liver disease. Hepatology (2009) 2.03
Abdominal wall hernias: imaging features, complications, and diagnostic pitfalls at multi-detector row CT. Radiographics (2005) 1.98
Effects of refocusing flip angle modulation and view ordering in 3D fast spin echo. Magn Reson Med (2008) 1.96
Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration. J Magn Reson Imaging (2012) 1.90
Influence of multichannel combination, parallel imaging and other reconstruction techniques on MRI noise characteristics. Magn Reson Imaging (2008) 1.82
SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastroenterology (2010) 1.81
Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology (2013) 1.77
T1 independent, T2* corrected MRI with accurate spectral modeling for quantification of fat: validation in a fat-water-SPIO phantom. J Magn Reson Imaging (2009) 1.71
Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver. AJR Am J Roentgenol (2010) 1.70
Combination of complex-based and magnitude-based multiecho water-fat separation for accurate quantification of fat-fraction. Magn Reson Med (2011) 1.67
Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms. J Magn Reson Imaging (2011) 1.66
Fat and water magnetic resonance imaging. J Magn Reson Imaging (2010) 1.64
Fast metabolic imaging of systems with sparse spectra: application for hyperpolarized 13C imaging. Magn Reson Med (2006) 1.64
MR imaging of liver fibrosis: current state of the art. Radiographics (2009) 1.62
Disproportionate fat stranding: a helpful CT sign in patients with acute abdominal pain. Radiographics (2004) 1.54
Quantification of hepatic steatosis with 3-T MR imaging: validation in ob/ob mice. Radiology (2010) 1.53
Quantification of liver fat with magnetic resonance imaging. Magn Reson Imaging Clin N Am (2010) 1.51
Optimal phased-array combination for spectroscopy. Magn Reson Imaging (2008) 1.48
Double-contrast MRI for accurate staging of hepatocellular carcinoma in patients with cirrhosis. AJR Am J Roentgenol (2008) 1.47
Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis. Radiographics (2009) 1.46
Radiogenomic analysis to identify imaging phenotypes associated with drug response gene expression programs in hepatocellular carcinoma. J Vasc Interv Radiol (2007) 1.42
Cardiac MRI of ischemic heart disease at 3 T: potential and challenges. Eur J Radiol (2008) 1.40
Advanced MRI methods for assessment of chronic liver disease. AJR Am J Roentgenol (2009) 1.39
Cross-sectional imaging of extranodal involvement in abdominopelvic lymphoproliferative malignancies. Radiographics (2007) 1.38
Magnetic resonance imaging quantification of liver iron. Magn Reson Imaging Clin N Am (2010) 1.37
Noninvasive assessment of hepatic steatosis. Clin Gastroenterol Hepatol (2008) 1.36
Generalized k-space decomposition with chemical shift correction for non-Cartesian water-fat imaging. Magn Reson Med (2008) 1.34
Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver. AJR Am J Roentgenol (2010) 1.33
CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology (2014) 1.33
LI-RADS (Liver Imaging Reporting and Data System): summary, discussion, and consensus of the LI-RADS Management Working Group and future directions. Hepatology (2014) 1.31
Cardiac CINE MR imaging with a 32-channel cardiac coil and parallel imaging: impact of acceleration factors on image quality and volumetric accuracy. J Magn Reson Imaging (2006) 1.25
Repeatability of magnetic resonance elastography for quantification of hepatic stiffness. J Magn Reson Imaging (2010) 1.23
Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results. Radiology (2012) 1.23
4D cardiovascular magnetic resonance velocity mapping of alterations of right heart flow patterns and main pulmonary artery hemodynamics in tetralogy of Fallot. J Cardiovasc Magn Reson (2012) 1.23
Water-fat separation with bipolar multiecho sequences. Magn Reson Med (2008) 1.22
CT appearance of the normal appendix in adults. Eur Radiol (2005) 1.21
Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial). Hepatology (2015) 1.18
The Stanford University experience with conventional-dose, total skin electron-beam therapy in the treatment of generalized patch or plaque (T2) and tumor (T3) mycosis fungoides. Arch Dermatol (2011) 1.16
Independent estimation of T*2 for water and fat for improved accuracy of fat quantification. Magn Reson Med (2010) 1.13
Cisterna chyli at routine abdominal MR imaging: a normal anatomic structure in the retrocrural space. Radiographics (2004) 1.11
Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical-shift gradient echo magnetic resonance imaging with histologic assessment as the reference standard. Invest Radiol (2012) 1.11
Articular cartilage of the knee: rapid three-dimensional MR imaging at 3.0 T with IDEAL balanced steady-state free precession--initial experience. Radiology (2006) 1.11
In vivo application of sub-second spiral chemical shift imaging (CSI) to hyperpolarized 13C metabolic imaging: comparison with phase-encoded CSI. J Magn Reson (2010) 1.11
Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features. Radiographics (2008) 1.10
3.0-T evaluation of knee cartilage by using three-dimensional IDEAL GRASS imaging: comparison with fast spin-echo imaging. Radiology (2010) 1.09
Pediatric nonalcoholic fatty liver disease: a comprehensive review. Adv Pediatr (2010) 1.08
Hepatobiliary MR imaging with gadolinium-based contrast agents. J Magn Reson Imaging (2012) 1.08
Imaging-based diagnostic systems for hepatocellular carcinoma. AJR Am J Roentgenol (2013) 1.08
Renal arteries: isotropic, high-spatial-resolution, unenhanced MR angiography with three-dimensional radial phase contrast. Radiology (2010) 1.08
Validation of MRI biomarkers of hepatic steatosis in the presence of iron overload in the ob/ob mouse. J Magn Reson Imaging (2011) 1.08
R*(2) mapping in the presence of macroscopic B₀ field variations. Magn Reson Med (2011) 1.06
Single breathhold cardiac CINE imaging with multi-echo three-dimensional hybrid radial SSFP acquisition. J Magn Reson Imaging (2010) 1.05
Noninvasive temperature mapping with MRI using chemical shift water-fat separation. Magn Reson Med (2010) 1.05
MR contrast agents for liver imaging: what, when, how. Radiographics (2006) 1.03
Single acquisition water-fat separation: feasibility study for dynamic imaging. Magn Reson Med (2006) 1.03
Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology (2014) 1.02
Phase and amplitude correction for multi-echo water-fat separation with bipolar acquisitions. J Magn Reson Imaging (2010) 1.02
In vivo validation of 4D flow MRI for assessing the hemodynamics of portal hypertension. J Magn Reson Imaging (2012) 1.02
Multipeak fat-corrected complex R2* relaxometry: theory, optimization, and clinical validation. Magn Reson Med (2013) 1.02
Constraining the initial phase in water-fat separation. Magn Reson Imaging (2010) 1.02
Noninvasive assessment of transstenotic pressure gradients in porcine renal artery stenoses by using vastly undersampled phase-contrast MR angiography. Radiology (2011) 1.01
T(2)-weighted 3D fast spin echo imaging with water-fat separation in a single acquisition. J Magn Reson Imaging (2010) 1.01
CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. Radiology (2014) 1.00
IDEAL imaging of the musculoskeletal system: robust water fat separation for uniform fat suppression, marrow evaluation, and cartilage imaging. AJR Am J Roentgenol (2007) 1.00
Quantification of thoracic blood flow using volumetric magnetic resonance imaging with radial velocity encoding: in vivo validation. Invest Radiol (2013) 0.99
Robustness of fat quantification using chemical shift imaging. Magn Reson Imaging (2011) 0.99
Optimized high-resolution contrast-enhanced hepatobiliary imaging at 3 tesla: a cross-over comparison of gadobenate dimeglumine and gadoxetic acid. J Magn Reson Imaging (2011) 0.98
The influence of prior hamstring injury on lengthening muscle tissue mechanics. J Biomech (2010) 0.98
Interleaved variable density sampling with a constrained parallel imaging reconstruction for dynamic contrast-enhanced MR angiography. Magn Reson Med (2011) 0.98
Characterization of hepatic adenoma and focal nodular hyperplasia with gadoxetic acid. J Magn Reson Imaging (2012) 0.97
Increased volume of coverage for abdominal contrast-enhanced MR angiography with two-dimensional autocalibrating parallel imaging: initial experience at 3.0 Tesla. J Magn Reson Imaging (2009) 0.96
Effects of postprandial state and mesenteric blood flow on the repeatability of MR elastography in asymptomatic subjects. J Magn Reson Imaging (2011) 0.95
Effects of intravenous gadolinium administration and flip angle on the assessment of liver fat signal fraction with opposed-phase and in-phase imaging. J Magn Reson Imaging (2008) 0.95
Hypotensive patients with blunt abdominal trauma: performance of screening US. Radiology (2005) 0.95